Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public ...

The support is designed to speed development of well-matched H5N1 vaccines and pave the way for vaccines against other ...

In this study, the authors estimated that Paxlovid reduced the risk of hospitalization by 39% (95% confidence interval [CI], ...

The Department of Health Services has awarded $590 million to Moderna to speed up the development of flu vaccines, including ...

Daily Podcasts & Video News – Keep up-to-date with the Thaiger while at work or on-the-go by listening in to the daily ...

Concerns about the COVID-19 shots have increased after a report that drug maker Moderna failed to inform the U.S. government ...

Shares of Moderna Inc. fell sharply on Monday after the biotech firm projected a steep decline in 2025 revenues, falling below Wall Street expectations. The company, known for its COVID-19 vaccine ...

1 Omicron subvariant. The Omicron booster made by Pfizer Inc. can be administered to people 12 and older, while Moderna Inc.’s Omicron booster is authorized for those 18 and older. In the past ...

Federal funding for COVID-19 vaccines will stop this year and the provinces and territories will be responsible for buying them, as well as determining the timing of the vaccinations, the Public ...

The most recent mRNA vaccines, manufactured by Pfizer-BioNTech and Moderna, target the KP.2 Omicron subvariant. Novavax's updated protein-based vaccine targets the JN.1 subvariant of Omicron ...

Less than a year after China identified the virus, health authorities in the U.S. and Britain cleared vaccines made by Pfizer and Moderna ... delta and omicron. Delta, which became dominant ...

For the past few days, reports of a massive flu outbreak in China have been circulating abroad, particularly in India and Indonesia. Health officials, however, maintain the outbreak is an annual ...